Commentary on “Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet‐dependent and ‐independent mechanisms” [PDF]
Bjarne Østerud
openalex +1 more source
Background. Pulmonary hemorrhage (PH) leads to acute and catastrophic deterioration in neonates, and there is no curative treatment available. Off-label use of recombinant Factor VIIa (rFVIIa) is a promising treatment to control bleeding.
Özge Serçe Pehlevan +3 more
doaj +1 more source
Recombinant factor VIIa: use in fatal post partum hemorrhage — Indian experience case series and review of literature [PDF]
Shailesh R. Singi +3 more
openalex +1 more source
Glanzmann’s thrombasthenia: A nightmare for hernia surgeons
Glanzmann’s thrombasthenia is a rare inherited disorder affecting one in one million. It is characterised by a lack of platelet aggregation due to a defect in the platelet membrane receptor complex (αIIb/βIIIa), which mediates the aggregation of ...
Jignesh Gandhi +3 more
doaj +1 more source
Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: The experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004–2008) [PDF]
Ellis J. Neufeld +4 more
openalex +1 more source
Use of Recombinant Factor VIIa Utilization Among a Hospitalized Pediatric Population [PDF]
Nathan E. Thompson +2 more
openalex +1 more source
Recombinant factor VIIa (NovoSeven®) for post‐prostatectomy hemorrhage in a patient with type I von Willebrand disease [PDF]
Michael D. Tarantino, Rozanne Aberle
openalex +1 more source
Injury of left sigmoid sinus treated with direct packing and recombinant factor VIIa: A case report
Piotr Paluszkiewicz +2 more
openalex +1 more source
Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding. [PDF]
Chang ZG +9 more
europepmc +1 more source

